NCT06986096

Brief Summary

Due to the increasing incidence of dementia and the lack of causal treatment, non-pharmacological interventions represent an attractive and effective therapeutic strategy of neurodegenerative diseases, such as Alzheimer's disease. The aim of the study is to assess the impact of a supervised 9-month intervention with aerobic-strength training and nutritional counseling compared to cognitive training and stretching on the brain, cognitive and motor functions, metabolism, physical fitnes and plasma markers of neurodegenertion in older adults at increased risk of developing Alzheimer's disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Sep 2024Dec 2026

First Submitted

Initial submission to the registry

July 15, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
9 months until next milestone

First Posted

Study publicly available on registry

May 22, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

2.2 years

First QC Date

July 15, 2024

Last Update Submit

May 22, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Impact on Cognitive Functions

    Overall composite score of neuropsychological testing batery (higher score better outcome)

    Measurements at the baseline and after 9-month intervention.

  • Effect of Interventions on Neurodegeneration Markers

    Concentration of plasma neurodegeneration marker pTau 217 (in a subpopulation of patients).

    Measurements at the baseline and after 9-month intervention

Secondary Outcomes (7)

  • Computerized Cognitive Tests

    Measurements at the baseline and after 9-month intervention.

  • Well-being

    Measurements at the baseline and after 9-month intervention.

  • Glucose metabolism

    Measurements at the baseline and after 9-month intervention.

  • MRI of the Brain

    Measurements at the baseline and after 9-month intervention.

  • Adherence

    Adherence will be recorded during the 9-month intervention period.

  • +2 more secondary outcomes

Study Arms (2)

Aerobic-strength training and nutritional counseling

EXPERIMENTAL

Elderly volunteers participating in aerobic-strength training and nutritional counseling.

Behavioral: Aerobic-strength training and nutritional counseling

Cognitive training and stretching.

EXPERIMENTAL

Elderly volunteers participating in cognitive training combined with stretching training.

Behavioral: Cognitive training and stretching.

Interventions

The intervention consists of a structured program that includes aerobic-strength training (1h training, 3 times per week) conducted by professional trainers combined with nutritional counseling.

Aerobic-strength training and nutritional counseling

The intervention consists of a structured program that includes cognitive training combined with stretching training (90mins training, 2x per week).

Cognitive training and stretching.

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-smokers
  • Signed informed consent
  • Presence of subjective or mild cognitive impairment (SCI/aMCI)
  • Elevated levels of selected biomarkers confirming the presence of a pathological process characteristic of Alzheimer's disease
  • Absence of any psychological, sociological, or geographical factors that could jeopardize participation in the project.

You may not qualify if:

  • Presence of severe cardiovascular, liver, or kidney diseases; advanced or poorly controlled diabetes mellitus (HbA1c \>7%), treated with insulin or incretin analogs; cancer or any other severe disease as assessed by the responsible physician. A history of cancer treated with chemotherapy or radiotherapy if within less than 5 years post-treatment.
  • Lack of cooperation, inflexible schedule, or problematic transportation.
  • Insufficient functional capacity or presence of comorbidities that prevent participation in the training program (assessment by an internist, cardiologist, neurologist, orthopedic specialist, or other relevant specialists).
  • Presence of a pacemaker or any metal implants (contraindication for MRI examination), or allergy to local anesthetics (contraindication for muscle biopsy).
  • Smoking, alcohol dependence, or addiction to other narcotic substances.
  • Stroke or myocardial infarction within the last year.
  • Other diseases of the musculoskeletal or nervous system that potentially interfere with the ability to exercise or cognition - such as severe arthritis, Parkinson's disease, significant essential tremor, epilepsy, etc.
  • Concurrent participation in another clinical study.
  • Therapy with cholinesterase inhibitors unless the patient is on a stable dose.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biomedical Research Center Slovak Academy of Sciences

Bratislava, Bratislava Region, 84505, Slovakia

RECRUITING

MeSH Terms

Conditions

Alzheimer DiseaseMotor ActivityCognitive Dysfunction

Interventions

Nutrition AssessmentCognitive Training

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersBehaviorCognition Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthNeurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Barbora Ukropcova, Prof.

    Biomedical Research Center Slovak Academy of Science

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Barbora Ukropcova, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
ID codes will be provided for the outcomes assessor, without group-specific characterization
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 15, 2024

First Posted

May 22, 2025

Study Start

September 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 29, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations